27N0 Stock Overview
Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cannovum Cannabis AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.97 |
52 Week High | €7.90 |
52 Week Low | €0.95 |
Beta | 0 |
11 Month Change | -31.34% |
3 Month Change | -57.97% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -60.61% |
Recent News & Updates
Recent updates
Shareholder Returns
27N0 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -14.5% | -2.7% | 1.5% |
1Y | n/a | -12.6% | 12.6% |
Return vs Industry: Insufficient data to determine how 27N0 performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 27N0 performed against the German Market.
Price Volatility
27N0 volatility | |
---|---|
27N0 Average Weekly Movement | 11.6% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 11.7% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 27N0's share price has been volatile over the past 3 months.
Volatility Over Time: 27N0's weekly volatility has decreased from 20% to 12% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | Pia Marten | cannovum.com |
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023.
Cannovum Cannabis AG Fundamentals Summary
27N0 fundamental statistics | |
---|---|
Market cap | €448.14k |
Earnings (TTM) | -€102.11k |
Revenue (TTM) | €1.82k |
0.0x
P/S Ratio0.0x
P/E RatioIs 27N0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
27N0 income statement (TTM) | |
---|---|
Revenue | €1.82k |
Cost of Revenue | €13.78k |
Gross Profit | -€11.96k |
Other Expenses | €90.16k |
Earnings | -€102.11k |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 27N0 perform over the long term?
See historical performance and comparison